Ultragenyx Pharmaceutical Inc.
2014 Q1 - 2025 Q4 (22 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 6,440 | 0.0% | 280,000 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 12,934 | 0.0% | 430,000 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 55,612 | 0.1% | 1,529,474 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 77,815 | 0.1% | 2,149,000 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 49,772 | 0.1% | 1,183,081 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 84,755 | 0.1% | 1,525,741 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 46,238 | 0.1% | 1,125,000 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 7,004 | 0.0% | 150,000 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 49,016 | 0.1% | 1,025,000 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 3,209 | 0.0% | 90,000 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 4,964 | 0.0% | 107,600 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 4,892 | 0.0% | 122,000 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 6,486 | 0.0% | 140,000 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 6,421 | 0.0% | 155,062 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 40,569 | 0.1% | 680,000 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 50,834 | 0.1% | 700,000 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 58,863 | 0.1% | 700,000 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 55,918 | 0.1% | 620,000 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 24,791 | 0.0% | 260,000 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 21,064 | 0.0% | 185,000 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 22,910 | 0.0% | 165,500 | 12/31/2020 |
| 2014 Q1 | 5/15/2014 | 89,996 | 0.2% | 1,840,783 | 3/31/2014 |